参考文献/References:
[1]Larsson C, Skogsied B, Oberg K, et al. Multiple endocrine neoplasia type1 gene maps to chromosome 11 and is lost in insulinoma . Nature, 1988, 332: 85 - 87.
[2]Steven K, Judy S, Lee Burns, et al. Parathyroid Gland- specific Deletion of the Mouse Men1 Gene Results in Parathyroid Neoplasia and Hypercalcemic Hyperparathyroidism. Cancer Research, 2003,63: 8022 - 8028.
[3]Bertolino P, Tong WM, Galendo D, et al. Hererozygous Men 1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1 . Mol Endocrinol, 2003, 17: 1880 -1992.
[4]Farnebo F, Teh B, Kytola S, et al. Alterations of the MEN1 gene in sporadic parathyroid tumor . J Clin Endocrinol Metab, 1998, 83:2627 - 2730.
[5]Chandrasekharappa S, Teh BT. Clinical and molecular aspects of multiple endocrine neoplasia type1 - for the book "Genetic Disoders of Endocrine Neoplasia" . Front Horm Rea, 2001, 28:50-80.
[6]Marx SJ, Niman LK. Aggressive pituitary tumors in MEN1: do they refute the two - hit model of tumorgenesis? J Clin Endocrinol.Metab, 2002, 87:453 -456.
[7]Teh BT. Multiple endocrine neoplasia type 1 . Molecular Genentics of Cancer, 2nd ed. BIOS Scientific publishers, 2001, 149 - 169.
[8]Goebel SU, Heppner AL, Burns, et al. Genotype/phenotype correlation of MEN1 gene mutations in sporadic gastrinomas. J Clin Endocrinol Metab, 2000, 85: 116 - 123.
[9]Uchino S, Noguchi S, Sato M, et al. Screening of the MEN1 gene and discovery of Germline and somatic mutation in apparently sporadic parathyroid tumors. Cancer Res, 2000, 60:5553 -5557.
[10]Guru SC, Prasad NB, Shin EJ, et al. Characterization of a MEN1 ortholog from Drosophila melanogaste. Gene, 2001, 263:31 -38.
[11]Wautot V, Khodael S, Frappart L, et al. Expression analysis of endogenous menin, the product of the multiple endocrine neoplasia type 1 gene, in cell lines and human tissues. Int J Cancer, 2000,85:877 -881.
[12]Ikeo Y, Sakurai A, Suzuki R, et al. Proliferation-associated expression of the MEN1 gene as revealed by in situ hybridization:possible role of the menin as a negative regulator of cell proliferation under DNA damage. Lab Invest, 2000, 80: 797 - 804.
[13]Suphapeetiporn K, Greally D, Walpita, et al. MEN1 tumoursuppressor protein localizes to telomeres during meiosis. Genes Chromosomes Cancer, 2002, 35:81 -85.
[14]Ikeo Y, Yumita W, Sakurai A, et al. JunD - Menin interaction regulates c - Jun - mediated AP - 1 transactivation. J Endocrine,2004, 51:333-342.
[15]Kim H, Lee JE, Cho EJ, et al. Menin, a tumor suppressor,represses JunD - mediated transcriptional activity by association with an mSin3A -Histone deacetylase complex. Cancer Res, 2003, 63:6135 -6139.
[16]De Caestecker MP, Piek E, Roberts AB. Role of transformation growth actor - β signaling in cancer. J Natl Cancer Inst (Bethesda) , 2000, 92: 1388 - 1402.
[17]Sowa H, Kaji H, Kitazawa R et al. Menin inactivation lead to loss of growth factor β inhibition of parathyroid cell prolifriration and parathyroid hormone secretion. Cancer Res, 2004, 64:2222 -2228.
[18]Swoa H, Kaji H, Hendy GN et al. Menin is required for BMP -2 -and TGF - β - regulated osteoblastic differentiation through interaction with Smads and Runx2. J Biol Chem, 2004, 279,24477 - 24484.
[19]Yaguchi H, Ohkura N, Tsukada T, et al. Menin, the mutiple endocrine neoplasia type 1 gene product, exhibits GTP -hydrolyzing activity in the presence of the tumor metastasis suppressor nm23. J Biol Chem, 2002, 277:38197-38204.
[20]Kim J, Kim D, Chung J. Replication protein A 32kDa subunit (RPA p32 ) binds the SH2 domain of Stat3 and regulates its transcriptional activity. Cell Biol Int, 2000, 24: 467 - 473.